Login / Signup

Response to: "Low levels of anti-SARS-CoV-2 antibodies after vaccination in rituximab- treated patients: Comment on article of Simon et al".

David SimonFilippo FagniKoray TascilarLarissa Valor-Méndez
Published in: Arthritis & rheumatology (Hoboken, N.J.) (2021)
Keyphrases
  • sars cov
  • newly diagnosed
  • end stage renal disease
  • ejection fraction
  • peritoneal dialysis
  • patient reported outcomes
  • respiratory syndrome coronavirus
  • coronavirus disease
  • patient reported